Latest S-1 registration statements

Elite Performance Holding Corp. has filed an amendment to its registration statement for a proposed initial public offering of 1,625,000 shares and a concurrent resale of 1,160,000 shares.

CH4 Natural Solutions Acquisition Corporation, a newly formed blank check company, aims to raise $250 million in an initial public offering to pursue a business combination in the agriculture and traditional energy sectors, focusing on methane mitigation.

Alpha One Inc. has filed an amendment to its S-1 registration statement to register 10 million shares of common stock for sale by existing shareholders.

Origin Investment Corp I, a newly formed blank check company, has filed an S-1 registration statement for an initial public offering of 6 million units at $10.00 each, aiming to effect a business combination primarily with target businesses in Asia's high-growth sectors.

International Land Alliance, a residential land development company, is planning a public offering of its common stock to facilitate a listing on the Nasdaq Capital Market.

Toppoint Holdings Inc. has filed an amendment to its S-1 registration statement primarily to include an updated consent from its independent auditor, TAAD, LLP.

Falcons Beyond Global, Inc. is offering $100 million of Class A common stock, with an underwriter option for an additional $15 million, to fund general corporate purposes.

Apimeds Pharmaceuticals US, Inc. has filed an amendment to its S-1 registration statement, indicating progress towards its initial public offering and plans to list on the NYSE American under the symbol APUS.

Cosmos Health Inc. is offering up to 10,714,286 shares of common stock, pre-funded warrants, and common warrants in a best-efforts offering.

Alpha Cognition Inc. has filed an amendment to its Form S-1 registration statement, detailing its commercialization strategy for ZUNVEYL and providing updates on its clinical programs and recent corporate activities.

Foxx Development Holdings is registering up to 12,145,917 common shares for issuance upon the exercise of outstanding warrants.

Aspargo Labs, a specialty pharmaceutical and med-tech company, has filed an S-1 registration statement for a direct listing of its common stock on the NYSE, aiming to raise capital for commercializing its Sildenafil Oral Suspension and developing innovative drug delivery devices.

Aspira Women's Health is offering up to 16 million shares of common stock and pre-funded warrants to raise capital, while also facing potential delisting from the Nasdaq Capital Market.

Catalyst Crew Technologies Corp. formalizes executive roles with new employment agreements and details its strategic focus on facial recognition technology.

NAYA Biosciences enters into a warrant agency agreement with Transfer Online, Inc. for its public offering involving common stock, pre-funded warrants, and common stock purchase warrants.

Functional Brands Inc. amends its asset purchase agreement related to the Kirkman acquisition and files an S-1 registration statement for an initial public offering.

DIH Holding US, Inc. has filed an exhibit detailing the terms of a Class A Common Stock Purchase Warrant, outlining conditions for exercise and adjustments.

Eastside Distilling registers 545,406 shares for resale by selling stockholders following a private placement related to its merger with Beeline Financial.

Callan JMB Inc. has filed an amendment to its registration statement for an initial public offering of 1,280,000 shares of common stock, with an expected price between $4.00 and $6.00 per share.

Ribbon Acquisition Corp, a blank check company, has filed an amendment to its S-1 registration statement for a $50 million initial public offering.

The Marquie Group, Inc. has filed an amendment to its S-1 registration statement, primarily to include updated exhibits, including legal and accounting consents.

Allurion Technologies plans to raise capital through an offering of common stock, pre-funded warrants, and common warrants.

Oragenics is launching a public offering of up to 15,151,515 units to fund the development of its ONP-002 drug for mild traumatic brain injury.

Nuburu, Inc. has filed a registration statement for the resale of up to 1,905,904 shares of its common stock by existing stockholders, primarily related to convertible notes and advisory services, as the company faces significant financial hurdles.

International Land Alliance, Inc. has filed an amendment to its Form S-1 registration statement for a proposed public offering of its common stock, aiming for a Nasdaq Capital Market listing.

Advanced Biomed Inc., a Nevada-based holding company, plans to raise capital through a $7.5 million common stock offering to fund cancer detection technology development and market expansion.

Lazydays Holdings initiates a rights offering to raise up to $25 million, providing existing shareholders the opportunity to purchase common stock at $1.03 per share.

Plum Acquisition Corp. IV, a blank check company, filed an amendment to its Form S-1 registration statement for a proposed $150 million initial public offering.

Maze Therapeutics, a clinical-stage biopharmaceutical company, has filed an S-1 registration statement for an initial public offering to fund the development of its precision medicines targeting renal, cardiovascular, and metabolic diseases.

NAYA Biosciences has filed an amendment to its registration statement for a unit offering of up to $13 million, including common stock or pre-funded warrants and common warrants.